Abstract:Gastric cancer (GC) remains a significant public health concern because of its lethality, underscoring the need for deeper insights into its molecular mechanisms. Recent studies have increasingly highlighted the role of epigenetic modifications as critical players in cancer progression. Despite their importance, research specifically addressing epigenetic factors in GC is relatively scarce. This paper seeks to bridge that gap by examining recent literature that elucidates the epigenetic landscape associated with GC. The investigation of long noncoding RNAs (lncRNAs) has revealed their substantial involvement in gene dysregulation and epigenetic alterations within GC tumors. Notably, lncRNAs such as LINC00853 and LINC01266 have been identified as significant contributors to the epigenetic modulation of gene expression. Furthermore, the overexpression of KAT5 and GPX4 has been shown to mitigate the antiproliferative effects resulting from the depletion of circRHOT1, suggesting a complex interplay between these molecules in GC pathophysiology. Another pivotal aspect of epigenetic regulation in GC involves modifications in N6-methyladenosine (m6A), which play crucial roles in mRNA maturation processes such as splicing, export, degradation, and translation. m6A modifications are known for their influence on various cancer-related pathways, thus presenting a potential avenue for targeted interventions. Our findings indicate that the most pronounced instances of epigenetic dysregulation in GC can be traced back to the effects of long lncRNAs and alterations in m6A modification patterns. This underscores the urgent need for comprehensive investigations into these epigenetic factors, as a deeper understanding could lead to enhanced diagnostic markers and innovative therapeutic strategies. The integration of genetic and epigenetic considerations is essential for advancing the field of GC research. This synthesis of recent findings concerning epigenetic regulation offers valuable insights that could inform future studies and therapeutic developments. There is a critical need for ongoing research to elucidate the complexities of epigenetic modifications in GC, ultimately improving patient outcomes through tailored interventions.

Methylation Modification In Gastric Cancer And Approaches To Targeted Epigenetic Therapy

Recent Progress in the Study of Methylated Tumor Suppressor Genes in Gastric Cancer

Gastric Cancer: an Epigenetic View

Gene methylation in gastric cancer

Epigenetic Regulation of DNA Methylation and RNA Interference in Gastric Cancer: A 2024 Update

Epigenetics on Gastric Cancer Research

DNA Methylation Drives a New Path in Gastric Cancer Early Detection: Current Impact and Prospects

Pathogenetic Mechanisms in Gastric Cancer

Gastric Cancer in the Era of Epigenetics

Epigenetic roles in the malignant transformation of gastric mucosal cells

Targeting Non-histone Methylation in Gastrointestinal Cancers: From biology to clinic

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives

Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities

Epigenetic Regulation of Micrornas in Gastric Cancer

The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer

Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance

Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis

Recent Advance of Histone Modification in Gastric Cancer : A Review

Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma

N 6 -methylation in the development, diagnosis, and treatment of gastric cancer

Emerging Molecular Classifications and Therapeutic Implications for Gastric Cancer